Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Capmatinib
Trade Name Tabrecta
Synonyms INC280|INC-280|INCB028060|INCB28060|INCB 28060
Drug Descriptions

Tabrecta (capmatinib) inhibits MET signaling and may induce cell death in tumors overexpressing MET or expressing constitutively activated MET (PMID: 31853265). Tabrecta (capmatinib) is FDA approved for use in patients with metastatic non-small cell lung cancer harboring MET exon 14 skipping mutations (FDA.gov).

DrugClasses MET Inhibitor 59
CAS Registry Number 1029712-80-8
NCIT ID C90564

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
A-1155463 + Capmatinib A-1155463 Capmatinib 0 0
Afatinib + Capmatinib Afatinib Capmatinib 0 0
Alectinib + Capmatinib Alectinib Capmatinib 0 0
Alpelisib + Capmatinib Alpelisib Capmatinib 0 0
Amivantamab-vmjw + Capmatinib Amivantamab-vmjw Capmatinib 0 1
Bevacizumab + Capmatinib Bevacizumab Capmatinib 0 1
Binimetinib + Capmatinib + Encorafenib Binimetinib Capmatinib Encorafenib 0 1
Buparlisib + Capmatinib Buparlisib Capmatinib 3 1
Capmatinib Capmatinib 0 15
Capmatinib + Ceritinib Capmatinib Ceritinib 0 0
Capmatinib + Cetuximab Capmatinib Cetuximab 0 1
Capmatinib + Dabrafenib + Trametinib Capmatinib Dabrafenib Trametinib 0 0
Capmatinib + Docetaxel Capmatinib Docetaxel 0 0
Capmatinib + Encorafenib Capmatinib Encorafenib 0 1
Capmatinib + Entrectinib Capmatinib Entrectinib 0 0
Capmatinib + Erlotinib Capmatinib Erlotinib 0 2
Capmatinib + Gefitinib Capmatinib Gefitinib 0 1
Capmatinib + Ieramilimab + Spartalizumab Capmatinib Ieramilimab Spartalizumab 0 1
Capmatinib + Lapatinib Capmatinib Lapatinib 0 0
Capmatinib + Lorlatinib Capmatinib Lorlatinib 0 0
Capmatinib + Merestinib Capmatinib Merestinib 0 0
Capmatinib + Nazartinib Capmatinib Nazartinib 0 3
Capmatinib + Neratinib Capmatinib Neratinib 0 1
Capmatinib + Nivolumab Capmatinib Nivolumab 0 1
Capmatinib + Osimertinib Capmatinib Osimertinib 0 2
Capmatinib + Osimertinib + Ramucirumab Capmatinib Osimertinib Ramucirumab 0 1
Capmatinib + Pembrolizumab Capmatinib Pembrolizumab 0 1
Capmatinib + Poziotinib Capmatinib Poziotinib 0 0
Capmatinib + S63845 Capmatinib S63845 0 0
Capmatinib + Sotorasib Capmatinib Sotorasib 0 0
Capmatinib + Spartalizumab Capmatinib Spartalizumab 0 5
Capmatinib + Trametinib Capmatinib Trametinib 0 1
Capmatinib + Venetoclax Capmatinib Venetoclax 0 0
Capmatinib + ZW25 Capmatinib ZW25 0 0


Additional content available in CKB BOOST